Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
CLOSTRIDIUM BOTULINUM TOXIN TYPE A HAEMAGGLUTININ COMPLEX
Ipsen Biopharm Limited
M03AX01
CLOSTRIDIUM BOTULINUM TOXIN TYPE A HAEMAGGLUTININ COMPLEX
10 Speywood units / Millilitre
Pdr for Soln for Injection
Product subject to prescription which may not be renewed (A)
Other muscle relaxants, peripherally acting agents
Authorised
2010-03-26
Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER AZZALURE, 10 SPEYWOOD UNITS/0.05 ML, POWDER FOR SOLUTION FOR INJECTION _(botulinum _toxin type A)_ _ READ ALL OF THIS LEAFLET CAREFULLY, BEFORE YOU START USING THIS MEDICINE, BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor. If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See Section 4. IN THIS LEAFLET: 1. What Azzalure is and what it is used for 2. What you need to know before you use Azzalure 3. How to use Azzalure 4. Possible side effects 5. How to store Azzalure 6. Contents of the pack and other information 1. WHAT AZZALURE IS AND WHAT IT IS USED FOR Azzalure contains a substance, botulinum toxin A, which causes muscles to relax. Azzalure acts at the junction between the nerves and muscle to prevent the release of a chemical messenger called acetylcholine from the nerve endings. This prevents muscles from contracting. The muscle relaxation is temporary and gradually wears off. Some people are distressed when lines appear on their face. Azzalure can be used in adults under 65 years to temporarily improve the appearance of any moderate to severe glabellar lines (the vertical frown lines between the eyebrows) and lateral canthal lines (crow’s feet lines). 2. WHAT YOU NEED TO KNOW BEFORE YOU USE AZZALURE DO NOT HAVE AN AZZALURE INJECTION IF: You are allergic to _Clostridium botulinum _toxin A or any of the other ingredients of this medicine (listed in section 6) You have an infection at the proposed site of injection You have myasthenia gravis, Eaton Lambert Syndrome or amyotrophic lateral sclerosis. WARNINGS AND PRECAUTIONS Talk to your doctor before you have the Azzalure injection if: You have any neuromuscular disorders You often have difficulty swallowing food (dysphagia) You find that you often have problems with food or drink getting into your air Preberite celoten dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Azzalure, 10 Speywood units/0.05ml, powder for solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Botulinum toxin type A* 10 Speywood units **/0.05 ml of reconstituted solution Vial of 125 units *_Clostridium botulinum_ toxin A haemagglutinin complex **One Speywood unit (U) is defined as the median lethal peritoneal dose in mice (LD50). The Speywood units of Azzalure are specific to the preparation and are not interchangeable with other preparations of botulinum toxin. For the full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Powder for solution for injection. The powder is white. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Azzalure is indicated for the temporary improvement in the appearance of moderate to severe: Glabellar lines (vertical lines between the eyebrows) seen at maximum frown and/or Lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology: Botulinum toxin units are different depending on the medicinal products. The Speywood units of Azzalure are specific to the preparation and are not interchangeable with other preparations of botulinum toxin. Paediatric population The safety and efficacy of Azzalure in individuals aged up to 18 years have not been established. The use of Azzalure is not recommended in subjects under 18 years. Method of administration: Azzalure should only be administered by physicians with appropriate qualifications and expertise in this treatment and having the required equipment. Once reconstituted, Azzalure should only be used to treat a single patient, during a single session. For instructions on reconstitution of the medicinal product before administration, see section 6.6. Remove any make-up and disinfect the skin with a local antiseptic. Intramuscular injections should be performed using a sterile Preberite celoten dokument